Nucana Plc ADR (NCNA)

$2.05 +0.37 (22.02%)
Market Cap 6.99M
Revenue (ttm) 0.00
Net Income (ttm) -38.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 133,100
Avg Vol 52,014
Day's Range N/A - N/A
Shares Out 4.16M
Stochastic %K 90%
Beta 1.79
Analysts Strong Buy
Price Target $25.00

Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate concentrations of anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 13 1357 1111
Address:
3 Lochside Way, Edinburgh, United Kingdom
NetworkProDesk
NetworkProDesk Apr. 8 at 6:07 AM
$NCNA biotech company NuCana.
0 · Reply
cycloon
cycloon Apr. 8 at 5:58 AM
$NCNA https://www.marketscreener.com/news/nucana-presentation-april-2026-0fa89e-ce7e51d3d18ef721
0 · Reply
SnowFlurry
SnowFlurry Apr. 8 at 12:01 AM
$NCNA
0 · Reply
Smug_Vortex
Smug_Vortex Apr. 7 at 9:12 PM
$NCNA The 2 dollar close is a beautiful thing Goddammit. Hope this continues. No reason why not. Unless big leverage slime manipulates the whole thing and rugs us like they’re known to do.
0 · Reply
ChickenClaw
ChickenClaw Apr. 7 at 7:56 PM
$NCNA This Is Not Even Trending Yet!
0 · Reply
ChickenClaw
ChickenClaw Apr. 7 at 7:54 PM
$NCNA Still 350% Away From Book Value.
0 · Reply
ChickenClaw
ChickenClaw Apr. 7 at 7:53 PM
$NCNA Such A Liar....You Said You Bought Pre-Split...That Means You woulda Had Millions Of Dollars In It...What A Liar! 200 To 1.
1 · Reply
Legends0fWick
Legends0fWick Apr. 7 at 6:52 PM
Small cap is hot, Massive breakout starting on CYCU 🚨 CYCU with massive cyber security news today. With just 2M float can CYCU be the next parabolic runner? Make sure you have ticker CYCU on watch. Market is looking super hot right now, CYCU can go big!! $$CMCT $PDSB $NCNA $KPRX .//.
1 · Reply
GreenEnergy1
GreenEnergy1 Apr. 7 at 6:49 PM
$NCNA Wish all luck. We break $5 and we’ll be selling our 50,000 shares. Still a massive loss, but a moment of optimism for sure. We’re still anticipating this is a rebuy occurring and it will drop below $1 before May.
0 · Reply
Smug_Vortex
Smug_Vortex Apr. 7 at 6:38 PM
$NCNA ⚠️ Attention Green Monkey… Green Monkey come in. Are you reading me? Over. ⚠️ We are experiencing price action despite your 24-7 FUD babblings. All systems are go. Over.
1 · Reply
Latest News on NCNA
NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update

Mar 19, 2026, 4:01 PM EDT - 19 days ago

NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update

NuCana Appoints Theresa Bruce as Chief Operating Officer

Jan 6, 2026, 8:00 AM EST - 3 months ago

NuCana Appoints Theresa Bruce as Chief Operating Officer

NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma

Dec 10, 2025, 8:00 AM EST - 4 months ago

NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma

NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 13, 2025, 4:01 PM EST - 5 months ago

NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China

Nov 5, 2025, 8:00 AM EST - 5 months ago

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China

NuCana Compliant with All Nasdaq Continued Listing Criteria

Sep 5, 2025, 8:00 AM EDT - 7 months ago

NuCana Compliant with All Nasdaq Continued Listing Criteria

NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025

Sep 3, 2025, 8:00 AM EDT - 7 months ago

NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025

NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 20, 2025, 4:05 PM EDT - 8 months ago

NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update

NuCana Announces ADS Ratio Change

Aug 1, 2025, 4:05 PM EDT - 8 months ago

NuCana Announces ADS Ratio Change

NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Jul 21, 2025, 8:05 AM EDT - 9 months ago

NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

NuCana Announces Plan to Implement ADS Ratio Change

Jul 11, 2025, 10:30 AM EDT - 9 months ago

NuCana Announces Plan to Implement ADS Ratio Change

NuCana Reports First Quarter 2025 Financial Results and Provides Business Update

Jun 2, 2025, 4:01 PM EDT - 11 months ago

NuCana Reports First Quarter 2025 Financial Results and Provides Business Update

NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Mar 20, 2025, 4:01 PM EDT - 1 year ago

NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Aurion Biotech Appoints Donald Munoz as Chief Financial Officer

Feb 10, 2025, 7:00 AM EST - 1 year ago

Aurion Biotech Appoints Donald Munoz as Chief Financial Officer

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 25, 2024, 7:00 AM EST - 1 year ago

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

Nov 11, 2024, 7:00 AM EST - 1 year ago

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

Baillie Gifford's Strategic Acquisition of NuCana PLC Shares

Oct 4, 2024, 12:03 PM EDT - 1 year ago

Baillie Gifford's Strategic Acquisition of NuCana PLC Shares

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

Sep 25, 2024, 4:01 PM EDT - 1 year ago

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

Sep 14, 2024, 3:01 AM EDT - 1 year ago

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study

Aug 29, 2024, 4:01 PM EDT - 1 year ago

NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 15, 2024, 4:01 PM EDT - 1 year ago

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update

NuCana to Present at the Jefferies Global Healthcare Conference

May 30, 2024, 8:36 AM EDT - 2 years ago

NuCana to Present at the Jefferies Global Healthcare Conference

NuCana to Present at TD Cowen's 5th Annual Oncology Innovation Summit

May 21, 2024, 8:00 AM EDT - 2 years ago

NuCana to Present at TD Cowen's 5th Annual Oncology Innovation Summit

NuCana Reports First Quarter 2024 Financial Results and Provides Business Update

May 16, 2024, 4:01 PM EDT - 2 years ago

NuCana Reports First Quarter 2024 Financial Results and Provides Business Update

NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

May 1, 2024, 4:01 PM EDT - 2 years ago

NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study

Apr 9, 2024, 4:30 PM EDT - 2 years ago

NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study

NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

Mar 20, 2024, 4:01 PM EDT - 2 years ago

NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

NuCana to Present at TD Cowen's 44th Annual Health Care Conference

Feb 27, 2024, 8:00 AM EST - 2 years ago

NuCana to Present at TD Cowen's 44th Annual Health Care Conference

NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 16, 2023, 4:01 PM EST - 2 years ago

NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update

NuCana Announces Listing Transfer to Nasdaq Capital Market

Nov 10, 2023, 4:01 PM EST - 2 years ago

NuCana Announces Listing Transfer to Nasdaq Capital Market

NuCana to Present at the Jefferies London Healthcare Conference

Nov 8, 2023, 4:01 PM EST - 2 years ago

NuCana to Present at the Jefferies London Healthcare Conference

NuCana to Participate in the Truist Securities 2023 BioPharma Symposium

Nov 1, 2023, 4:01 PM EDT - 2 years ago

NuCana to Participate in the Truist Securities 2023 BioPharma Symposium

NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Oct 16, 2023, 7:00 AM EDT - 2 years ago

NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Oct 13, 2023, 12:30 PM EDT - 2 years ago

NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Sep 18, 2023, 8:00 AM EDT - 2 years ago

NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 16, 2023, 4:01 PM EDT - 2 years ago

NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update

NuCana to Present at the Jefferies Healthcare Conference

Jun 1, 2023, 8:00 AM EDT - 3 years ago

NuCana to Present at the Jefferies Healthcare Conference

NuCana Reports First Quarter 2023 Financial Results and Provides Business Update

May 17, 2023, 4:01 PM EDT - 3 years ago

NuCana Reports First Quarter 2023 Financial Results and Provides Business Update

NuCana Announces Receipt of Nasdaq Notice

May 12, 2023, 4:01 PM EDT - 3 years ago

NuCana Announces Receipt of Nasdaq Notice

NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action

Apr 14, 2023, 8:00 AM EDT - 3 years ago

NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action

NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update

Apr 4, 2023, 4:01 PM EDT - 3 years ago

NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update

Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana's ‘190 Patent is Not Valid

Mar 24, 2023, 4:30 PM EDT - 3 years ago

Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana's ‘190 Patent is Not Valid

NuCana to Participate in Two Upcoming Investor Conferences

Feb 28, 2023, 8:00 AM EST - 3 years ago

NuCana to Participate in Two Upcoming Investor Conferences

NuCana Announces Receipt of NASDAQ Notice

Jan 6, 2023, 4:01 PM EST - 3 years ago

NuCana Announces Receipt of NASDAQ Notice

NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update

Nov 16, 2022, 4:01 PM EST - 3 years ago

NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update

NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022

Oct 26, 2022, 7:00 AM EDT - 3 years ago

NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022

NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

Sep 12, 2022, 10:45 AM EDT - 3 years ago

NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

NuCana Announces Presentations at the European Society for Medical Oncology (ESMO) Congress 2022

Sep 6, 2022, 8:00 AM EDT - 3 years ago

NuCana Announces Presentations at the European Society for Medical Oncology (ESMO) Congress 2022

NuCana to Participate in Citi's 17th Annual BioPharma Conference

Aug 31, 2022, 8:00 AM EDT - 3 years ago

NuCana to Participate in Citi's 17th Annual BioPharma Conference

NuCana Reports Second Quarter 2022 Financial Results and Provides Business Update

Aug 17, 2022, 4:01 PM EDT - 3 years ago

NuCana Reports Second Quarter 2022 Financial Results and Provides Business Update

NetworkProDesk
NetworkProDesk Apr. 8 at 6:07 AM
$NCNA biotech company NuCana.
0 · Reply
cycloon
cycloon Apr. 8 at 5:58 AM
$NCNA https://www.marketscreener.com/news/nucana-presentation-april-2026-0fa89e-ce7e51d3d18ef721
0 · Reply
SnowFlurry
SnowFlurry Apr. 8 at 12:01 AM
$NCNA
0 · Reply
Smug_Vortex
Smug_Vortex Apr. 7 at 9:12 PM
$NCNA The 2 dollar close is a beautiful thing Goddammit. Hope this continues. No reason why not. Unless big leverage slime manipulates the whole thing and rugs us like they’re known to do.
0 · Reply
ChickenClaw
ChickenClaw Apr. 7 at 7:56 PM
$NCNA This Is Not Even Trending Yet!
0 · Reply
ChickenClaw
ChickenClaw Apr. 7 at 7:54 PM
$NCNA Still 350% Away From Book Value.
0 · Reply
ChickenClaw
ChickenClaw Apr. 7 at 7:53 PM
$NCNA Such A Liar....You Said You Bought Pre-Split...That Means You woulda Had Millions Of Dollars In It...What A Liar! 200 To 1.
1 · Reply
Legends0fWick
Legends0fWick Apr. 7 at 6:52 PM
Small cap is hot, Massive breakout starting on CYCU 🚨 CYCU with massive cyber security news today. With just 2M float can CYCU be the next parabolic runner? Make sure you have ticker CYCU on watch. Market is looking super hot right now, CYCU can go big!! $$CMCT $PDSB $NCNA $KPRX .//.
1 · Reply
GreenEnergy1
GreenEnergy1 Apr. 7 at 6:49 PM
$NCNA Wish all luck. We break $5 and we’ll be selling our 50,000 shares. Still a massive loss, but a moment of optimism for sure. We’re still anticipating this is a rebuy occurring and it will drop below $1 before May.
0 · Reply
Smug_Vortex
Smug_Vortex Apr. 7 at 6:38 PM
$NCNA ⚠️ Attention Green Monkey… Green Monkey come in. Are you reading me? Over. ⚠️ We are experiencing price action despite your 24-7 FUD babblings. All systems are go. Over.
1 · Reply
piotrek123082
piotrek123082 Apr. 7 at 6:36 PM
$NCNA O! DANG! So much for creeping up....
0 · Reply
piotrek123082
piotrek123082 Apr. 7 at 6:15 PM
$NCNA Still creep8ng up and up day by day , somwone is loading upBUT really quietly 🤫
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Apr. 7 at 5:57 PM
$NCNA
0 · Reply
ChickenClaw
ChickenClaw Apr. 7 at 5:56 PM
$NCNA Book Value $7.87
0 · Reply
ChickenClaw
ChickenClaw Apr. 7 at 4:43 PM
$NCNA I Will Type Slower For Ya...Fire Him Or Her....That Person Told Ya To Buy And You Lost 98% ! Fire That Person! Share Structure Looks Great Now On NCNA.
1 · Reply
GreenEnergy1
GreenEnergy1 Apr. 7 at 4:29 PM
$NCNA We’re up 140% on ACRS in the past year since we bought it. A lot better than down 98.9% with NCNA!
0 · Reply
Smug_Vortex
Smug_Vortex Apr. 7 at 4:18 PM
$NCNA 💪⬆️ LFG!
0 · Reply
cycloon
cycloon Apr. 7 at 3:37 PM
$NCNA Where can we go?
1 · Reply
cycloon
cycloon Apr. 7 at 3:21 PM
$NCNA
0 · Reply
ChickenClaw
ChickenClaw Apr. 7 at 3:20 PM
$NCNA I Repeat...Fire Your Financial Advisor!!! It Will Save You Money.
0 · Reply
GreenEnergy1
GreenEnergy1 Apr. 7 at 2:16 PM
$NCNA ACRS is a better pharma gamble. Price forecast of $8 and currently sitting at $3.70. NCNA forecast of $.02
1 · Reply
piotrek123082
piotrek123082 Apr. 7 at 2:05 PM
$NCNA at least this one is up a bit
0 · Reply